Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5686942 | The Journal of Urology | 2017 | 19 Pages |
Abstract
Lipotoxin failed to demonstrate a positive proof of concept compared to onabotulinumtoxinA or placebo. However, a single intravesical instillation of lipotoxin was associated with decreased interstitial cystitis/bladder pain syndrome symptoms compared to baseline in patients with moderate to severe interstitial cystitis/bladder pain syndrome. The effect was likely due to a significant placebo effect.
Keywords
VASFBCOnabotulinumtoxinAICPIN/SOABBPSUTIInterstitial Cystitis Problem IndexPost-void residual urineglobal response assessmentOSSGRAPelvic painnormal salinebotulinum toxinBladder pain syndromeInterstitial cystitisInterstitial Cystitis Symptom IndexPVRadverse eventurinary tract infectionLiposomeUrinary bladderOveractive bladdervisual analog scaleICSI
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Yao-Chi Chuang, Hann-Chorng Kuo,